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The Chediak-Higashi Syndrome: Spectrum of Giant Organelles 
in Peripheral Blood Cells 
James G. White, MD* and C. C. Clawson, MD ' 
The presence of giant organelles in the cytoplasm of pe-
ripheral blood elements is diagnostic for the Chediak-
Higashi syndrome. These abnormal cytoplasmic inclusions 
are found within neutrophils, eosinophils, basophils, lym-
phocytes, monocytes, and platelets. Their fine structural 
characteristics differ. Neutrophils demonstrate striking vari-
ability in the size, shape, and internal features of their giant 
organelles. Lymphocytes contain two different types ofgiant 
inclusions, one with a smoothly homogeneous substructure, 
the other with structures resembling microtubules. Empha-
sizing the ultrastructural similarities and differences ofthese 
anomalous granulations may provide valuable clues for 
understanding the basic defect of this inherited disorder. 
Introduction 
Desp i te the extreme rarity of patients with the Chediak-
Higashi syndrome (CHS), this disorder has attracted intense 
interest since it was initially described (1-4). Pigmentary 
dilution resulting in pseudo-albinism, an increased suscep-
tibility to pyogenic infections, an accelerated phase char-
acterized by lymphadenopathy, heptosplenomegaly, pan-
cytopenia, and a terminal process resembling a lympho-
reticular malignancy (5,6) represent its typical clinical fea-
tures. Most patients die in early childhood from infection, 
complications of the accelerated phase, or from the un-
usual lymphoreticular malignancy (7). 
Giant organelles, present in the cytoplasm of most pe-
ripheral blood cells, are diagnostic of CHS. The massive 
leukocyte inclusions have been particularly intriguing. 
They have been subjected to many biochemical, histo-
chemical, cytochemical, and immunochemical procedures 
and explored in detail by light, phase contrast, and electron 
microscopy in attempts to define their nature, origin, and 
role in the disease (8-22). Because the patients are prone to 
bacterial infection, most studies have focused on the poly-
morphonuclear leukocyte (PMN). Investigations of neu-
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t rophi l precursors in bone marrow from patients and 
animal models suggested that azurophilic lysosomes de-
veloping in promyelocytes undergo fusion during matura-
tion to form the giant inclusions observed in peripheral 
blood cells (10,11,15,17,23-29). Consequently, various in-
vestigators concluded that the process of fusion was exclu-
sively concerned with the azurophilic organelles in the 
promyelocytes and myelocytes, that itwas complete before 
the cells entered the peripheral blood, and that the non-
lysosomal organelles, called specific or secondary gran-
ules, were not involved in the evolution of giant organelles 
(17,18,25,26,28). This view of giant CHS inclusions has 
been used to explain the development of giant granules in 
other CHS leukocytes, tissue cells, and organs of the body. 
However, early studies in our laboratory did not agree with 
this prevailing concept (11,12). Although azurophilic gran-
ules were involved in the formation ofthe large inclusions, 
the process was not complete in the bone marrow. Rather, 
fusion between giant organelles and normal-sized granules 
cont inued in the mature PMN, and nonlysosomal or-
ganelles as well as azurophilic lysosomes were involved. In 
addition, we demonstrated other manifestations of the dis-
ease in CHS leukocytes, including a process resembling 
cytoplasmic sequestration (12). Recent immunochemical 
studies have confirmed and extended our early findings by 
demonstrating that markers for both primary azurophilic 
lysosomes and specific secondary granules are present in 
the giant CHS inclusions (30). 
As a result of these studies (11,12,31), it is clear that the 
prevailing concept of giant granule formation in CHS neu-
trophils needs to be modified. Furthermore, based on our 
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recent investigations, the use of this concept to explain the 
development of giant granules in other blood cells, tissues, 
and organs in patients with CHS is no longer tenable. The 
purpose of this report is to demonstrate that in each type of 
blood cell there are unique features of giant granule forma-
tion that do not conform to the prevailing concept. 
Materials and Methods 
Patients 
The present study is based on the examination of blood 
samples from three patients with the characteristic clinical 
and laboratory features of CHS, although two of the pa-
tients are no longer available for study. The third, a thirteen-
year-old boy currently in excellent health, has been evalu-
ated annually for the past nine years. The diagnosis of CHS 
was made shortly after his birth. He developed a parotid 
abscess in the newborn nursery, and blood smears revealed 
cytoplasmic inclusions in his leukocytes typical of CHS. 
Infections were frequent duringthe first few years of his life, 
but in the past eight years they have been no more frequent 
than in normal children of comparable age. He has no 
signs of the accelerated phase of the disease. Giant 
organelles typical of CHS have been observed in ker-
otinocytes, melanocytes, peripheral blood cells, and bone 
marrow. His mother and father are unrelated, and his only 
sibling, a sister, has no evidence of CHS. Most of our recent 
studies have been carried out on blood samples from this 
patient. 
Preparation of white blood cell samples 
Several different procedures have been used to collect 
leukocytes from patients with CHS. In early studies we 
depended on buffy coat samples of whole blood collected 
in a ratio of 9:1 with 3.8% tri-sodium citrate anticoagulant 
and sedimented at room temperature under a force of 200 
x g (11,12). Subsequently, we have separated CHS leuko-
cytes from whole b lood, wh ich was col lected in 
heparinized syringes, by dextran sedimentation and by a 
sequential procedure involving dextran sedimentation, iso-
lation on ficoll-hypaque density gradients, and subsequent 
washing and resuspension in Hanks' balanced salt solution 
(31,32). All methods have yielded excellent white cell 
preparations, but each is employed to provide samples 
enriched in a particular cell type. Buffy coats and samples 
obtained by dextran sedimentation yield all varieties of 
leukocytes and platelets. Ficoll-hypaque provides samples 
rich in lymphocytes, monocytes, platelets, and basophils, 
while the combination of dextran sedimentation and ficoll-
hypaque isolation provides nearly pure samples of gran-
ulocytes (33). 
Preparation of samples for cytochemistry and electron 
microscopy 
The basic procedure we developed for fixation of blood 
cells initially requires combining the leukocytes with an 
equal volume of 0.1% glutaraldehyde in White's saline, pH 
7.4, followed by sedimentation of the cells to a pellet and 
subsequent fixation in 3% glutaraldehyde buffered in 
White's saline, pH 7.4, for 30-60 minutes at 4°C. For 
cytochemical studies, the second phase of fixation utilizes 
0.5% glutaraldehyde and 2.5% paraformaldehyde in 0.1M 
cacodylate buffer. The procedures for demonstrating acid 
phosphatase (12) and myeloperoxidase (35) in leukocytes 
have been described in detail in previous publications. 
After initial fixation in glutaraldehyde or after incubation 
for enzyme activities, the samples were post-fixed in either 
1% osmic acid in Zetterquist's buffer, pH 7.3, 1% osmic 
acid in 0.1M phosphate buffer, or 1% osmic acid in distilled 
water containing 1.5% potassium ferrocyanide (36). All 
fixed samples were dehydrated in a graded series of alco-
hols and embedded in Epon 812. Thin sections cut on an 
ultra-microtome were either stained with lead citrate and 
uranyl acetate or examined unstained if enzyme activities 
were to be localized. The sections were studied in a Philips 
301 electron microscope. 
Results 
Polymorphonuclear leukocytes (PMN) 
Thin sections of well-preserved CHS neutrophils reveal a 
striking variability in the size, shape, and internal structure 
of giant organelles in their cytoplasm (Figs. 1, 2). Some of 
the enlarged bodies have rounded contours or are spindle 
shaped. Their enclosing membranes are sharply demar-
cated, and the material inside is homogenous, often with a 
periodic, linear substructure. This type of giant organelle 
most closely resembles the azurophilic granule, or primary 
lysosome, ofthe mature normal PMN and its bone marrow 
precursors. When viewed in the l ight microscope on 
Wright-stained blood smears, this form is sharply demar-
cated, usually spherical in shape, and stains a darker 
purple color than other large masses in the CHS neutrophil. 
It is reasonably well established that this type of massive 
inclusion arises through fusion of smaller, perhaps normal-
sized, primary lysosomes during maturation of CHS neu-
trophils in the bone marrow (Fig. 3). 
Asecond variety of giant organelle is usually largerthan the 
first, very irregular in surface contour, and highly variable 
in the organization, structure, and electron density of its 
internal content (Figs. 1, 2). This type is encountered more 
freqently in mature CHS neutrophils than the first variety 
and appears to occupy larger volumes of the cel l 
cytoplasm. These giant inclusions correspond to the irregu-
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Fig. 1. PMN from a patient wi th CHS 
Cell is irregular in form wi th a few short pseudopods evident on its 
surface. A large number of organelles occupy the cytoplasm, but only a 
single lobe of the nucleus (N) is evident. Dark particles of glycogen (Gly) 
are spread evenly throughout the cell and a single multivesicular body 
(MVB) is apparent. Normal-sized specific or secondary granules (SG) are 
dispersed throughout the cytoplasm. Three types of giant CHS organelles 
are evident: 1) sharply defined borders; generally round or spindle-
shaped; it closely resembles azurophilic granules in promyelocytes and 
myelocytes; 2) irregular in fo rm; electron density varies considerably; 
some appear swollen or in stages of degeneration, whi le others are intact; 
3) double-ringed organelle in which cytoplasmic constituents are se-
questered (X19,500). 
lar, gray-blue structures present in the cytoplasm of CHS 
neutrophils viewed in the light microscope. In thin section, 
the internal matrix of the giant bodies displays a range of 
appearances. At one end of the spectrum the basic sub-
stance is similar to the matrix material of the first form of 
massive particle and may include areas in which a periodic 
linear substructure can be defined. For the most part, 
however, the matrix is mottled with zones of differing 
density which often surround masses of ill-defined mem-
branous residues. On occasion the membrane residues are 
in parallel alignment, producing the appearance of myelin 
configurations. Previous studies have shown that these 
giant inclusions are unusually permeable to vital dyes (11). 
Increased permeability could permit water to leak into the 
massive bodies before or during fixation, resulting in a 
swollen appearance and separation of the contents present 
in some inclusions. The similarity of some of the enlarged 
structures to bags of degenerating debris was far more 
common when osmic acid was used as the only fixative (11) 
Fig. 2. CHS neutrophil 
Several lobes of the nucleus (N) are evident. Giant granules of the first 
type (1) are apparent in this and an adjacent cel l . The second variety (2) is 
present in two forms, intact and di luted. Sites where fusion (F) appears to 
be occurring between small granules (SG) and the massive inclusions can 
be identified around the irregular borders of both giant organelles 
(XI 7,000). 
but can still be observed in well-preserved cells after 
glutaraldehyde-osmium fixation. 
Although the variable content and substructural organiza-
tion ofthis form ofgiant organelle has attracted a great deal 
of attention, the tortuous border is the most interesting 
feature of the inclusion. Careful examination of enclosing 
membranes reveals multiple sites of interaction with nor-
mal-sized organelles in the surrounding cytoplasm. In 
some areas, the membrane of an adjacent organelle, 
whether a primary or secondary granule, fuses with the 
surface of the giant body. In a few zones, an entire small 
organelle appears to have been incorporated. Nucleoids 
from the smaller organelles are dense and contribute to the 
opaque areas after fusion. Membranous residues in the 
large, irregular organelles may come from the nucleoids of 
small organelles but may also derive from surfaces of 
normal-sized granules. 
When it was first proposed that giant granules continue to 
fuse with small organelles, even in mature PMN, and that 
secondary granules as well as azurophilic lysosomes (11,12) 
were incorporated, considerable controversy resulted (37). 
Yet, even a cursory examination of well-preserved CHS 
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within double rings of membrane react for both acid phos-
phatase and myeloperoxidase. We have previously de-
scribed stages in the degradation of cytoplasmic 
constituents enclosed by the double ring confining lysoso-
mal enzymes (12), and the precise relationship of these 
areas of cytoplasmic sequestration to the two major giant 
inclusions wil l be the subject of a separate report. 
It is surprising that PMN from patients with CHS filled with 
several varieties of giant lysosomes appear to survive nor-
mally once they reach the peripheral circulation, since 
patients usually have a neutropenia attributed to destruc-
tion of maturing precursors in the bone marrow or a 
mechanical inability to leave it (22,38). Nevertheless, one 
might question whether the cells survive normally because 
frequently we have found what appear to be dead or dying 
PMN in peripheral blood samples (Fig. 4). The dead cells 
have rounded contours, subsurface membrane vesicula-
tion, condensed nuclei and cytoplasm, and sequestered 
masses of glycogen. We have never encountered such cells 
in the blood of normal individuals or of patients with other 
blood diseases. 
Fig. 3. CHS neutrophil reacted for peroxidase 
Nuclear lobes (N), specific granules (SG), and glycogen particles are 
distributed throughout the cytoplasm. Dense reaction product specific for 
peroxidase is confined to massive organelles as well as small azurophilic 
granules (AG). Some peroxidase positive organelles have smooth surface 
contours, while most are irregular. The possibility that fusion continues 
between large and small organelles in peripheral CHS neutrophils is 
strongly suggested (XI 7,000). 
peripheral blood cells in thin section reveals that this 
concept is reasonable. The granules are huge, often with 
five or more giant inclusions in the plane of sectioned 
cytoplasm in a single cell. Also, all CHS neutrophils ap-
pear to contain several of the massive bodies. Considering 
the sheer mass of material in the giant inclusions and the 
large volume of cytoplasm they occupy, it would be vir-
tually impossible for them to represent the normal amount 
of azurophilic granule substance produced during matura-
t ion of PMN. However, the concept that the giant 
organelles interacted with both primary and secondary 
granules in mature CHS neutrophils has failed to gain 
acceptance until recently. Rausch, et al have recently dem-
onstrated by employing fluorescent tagged antibodies spe-
cif ic for components of either primary lysosomes or 
secondary granules, but not both, that the giant organelles 
of CHS neutrophils contain both azurophilic and specific 
granule markers (30). Their findings corroborate previous 
ultrastructural studies which lacked a specific marker for 
secondary granules. 
The third variety of aberrant inclusion in PMN resembles 
an autophagic vacuole. Cytoplasmic contents enclosed 
Eosinophils 
Eosinophils on peripheral blood smears of patients with 
CHS are characteristic of the disease and confirm the 
diagnosis (Fig. 5). While giant granules are always present 
in CHS eosinophils and occur in no other human disease, 
little attention has been paid to their development. It is 
reasonably clear that the giant eosinophil granules develop 
by fusion of smaller organelles (Fig. 6). Normal eosinophil 
granules contain a single crystalloid in their substructure, 
but the enlarged granules usually contain several of the 
typical crystalloids. The larger they are, the more crystals 
they may contain. Yet, among the massive inclusions in 
CHS eosinophils are smaller granules similar in size and 
appearance to those in normal cells. The cells vary consid-
erably in the balance between very large inclusions and 
more normal-sized granules, but the CHS eosinophils with 
large inclusions have fewer individual storage granules 
than those with generally smaller organelles (Fig. 7). It 
seems reasonable that the larger organelles evolve at the 
expense of the smaller and that the fusion process contin-
ues in mature cells. 
In contrast to the PMN, there is l i t t le evidence of 
cytoplasmic injury in CHS eosinophils. Irregular, giant 
inclusions similar to the second variety observed in every 
neutrophil are rarely evident. It is surprising thatthey ever 
occur in eosinophils, which lack secondary granules of the 
type found in PMN, but their rarity offers further support for 
the concept that secondary granules are involved in form-
ing giant inclusions in PMN. 
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Fig. 4. CHS neutrophil 
This type of cell is rare in peripheral blood of patients wi th CHS but more 
frequent in patient samples than in normal blood. It has no pseudopods 
and is nearly spherical. Vesiculation is apparent just under the surface 
membrane. Nuclear (N) lobes and the entire cytoplasm appear con-
densed. PMN of this type do not appear to be functional and may be in an 
advanced stage of cell death (X25,000). 
Fig. 6. CHS eosinophil reacted for peroxidase 
Huge organelles containing several crystalloids as well as normal-sized 
granules wi th dense reaction product are apparent (XI7,700). 
Fig. 5. CHS eosinophil 
Nucleus (N) is eccentric. Cytoplasm contains organelles ranging from 
normal sized to huge; large organelles may contain a single crystal (C) or 
many crystalloids (X18,200). 
Fig. 7. CHS eosinophil 
This cell contains one giant granule (GG) almost as large as a nuclear lobe 
(N). Small granules are also apparent in the cytoplasm (X19,000). 
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Occasional giant granules in CHS eosinophils are poorly 
preserved in thin sections. The apparent swelling and 
dissolution of internal contents may be a fixation artifact. 
However, since it has been shown that the massive inclu-
sions are more permeable to vital dyes (11,39), this defect 
may result in the swollen appearance which resembles the 
changes observed in some of the massive inclusions of 
PMN. Despite this, right-shaped, double membrane-en-
closed areas resembling autophagic vacuoles, which are 
common in CHS neutrophils, have rarely been observed in 
eosinophils from CHS patients. 
Basophils 
All CHS basophils examined in thin sections have con-
tained massively enlarged organelles (Figs. 8, 9). It is 
possible that they contain an admixture of giant and more 
normal-sized granules, but too few have been observed to 
permit such a conclusion. Many giant basophil inclusions 
appear to be massively enlarged granules of the type seen 
in normal cells. Others seem swollen, as if they had taken 
up water before or during fixation, and their contents 
appear diluted. The resemblance of the swollen giant 
inclusions to simi lar ly altered massive granules in 
eosinophils and PMN is striking and suggests that huge 
organelles in the circulating granulocytes may be sub-
ject to mechanical injury in vivo or may be damaged 
during separation of the cells in vitro. Giant granules of 
CHS basophils often contain small crystalline inclusions 
which are most easily recognized in the swollen organelles 
but can also be observed in giant granules with intact 
structure. Crystals of the type found in CHS basophil 
inclusions do not appear in normal basophil granules and 
may develop in the giant organelles after fusion has oc-
curred. Their origin is unknown. In some giant basophil 
granules the crystalline structures are quite large, resem-
bling the multiplex crystals ofthe huge eosinophil granules. 
Lymphocytes 
Giant granules are found in about 40% of CHS lymphocytes 
in thin sections, which agrees well with the 50-90% found 
by light microscopy. Two major types of giant inclusion 
are present in the cytoplasm of CHS lymphocytes. One 
appears to be smoothly homogenous in substructure or to 
contain two or more zones of d i f fer ing compos i t ion 
(Fig. 10). Droplets resembling lipid and very dense deposits 
associated with them are often present, suggesting the 
appearance of ceroid or lipofuchsin. Lipid droplets and 
dense material may be surrounded by a matrix of protein or 
be complexed to a large organelle within the same enclosing 
membrane. Cytochemical studies (11) have shown that this 
type of organelle is acid phosphatase positive (Fig. 11). 
Reaction product of acid phosphatase may fill the matrix or 
be deposited only in a peripheral ring or on one side of the 
Fig 8. CHS basophil 
Several giant granules surround the nucleus (N); one appears swollen but 
retains a crystalloid element (C) (XI7,000). 
Fig. 9. CHS basophil 
Crystalline (C) structures are evident in several giant granules (X15,500). 
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Fig. 10. CHS lymphocyte 
Giant granule (GG) is clearly larger than multivesicular body (MVB) in the 
cytoplasm. The huge inclusion contains a dense core and less dense 
material around the periphery (X19,000). 
Fig. 12. CHS lymphocyte 
Giant organelle in the cytoplasm of this cell contains large numbers of 
circular profiles resembling microtubules and is referred to as a tubular 
inclusion (Tl) (X22,000). 
11 
Fig. 11. CHS lymphocyte reacted for acid phosphatase activity 
Dense reaction product is local ized to a rim around the unreactive core of 
the giant granule (GG) (X27,000). 
Fig. 13. CHS lymphocyte 
Giant tubular inclusion shown here contains innumerable circular profiles 
resembling microtubules (X49,500). 
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massive inclusion. The distribution of reaction product 
suggests that the giant organelles have developed by fusion 
and that lysosomal enzymes may be sequestered as a result. 
The second variety of giant inclusion (Fig. 12) is filled with 
structures resembling microtubules (34). Although small 
organelles containing tubules are also present in about 5% 
of normal lymphocytes, they reach massive proportions in 
CHS lymphocytes (Fig. 13). Normal cells may have five or 
six of the tubule-filled organelles, whereas CHS lympho-
cytes usually reveal only one or two. The mechanism 
involved in their evolution is still being evaluated. In our 
original study they appeared to arise from thecytoplasm and 
to be sequestered within membranes, i.e., the groups of 
tubules formed first and were then surrounded by a mem-
brane. This finding was supported by the observation that 
small granules and cytoplasmic debris were often enclosed 
by the same membrane as the tubular elements. Although 
the tubular elements themselves were cytochemically inert, 
they were occasionally surrounded by a ring of acid phos-
phatase (34). Either the enzyme was enclosed with masses of 
tubules at the time the surrounding membrane developed, 
or granules subsequently fused with the tubules to form 
secondary lysosomes. While the latter possibility seemed 
more likely, the initial mechanism whereby giant tubular 
inclusions develop did not appear to involve fusion of 
smaller organelles. Rather, the masses of tubular material 
developed in the cell cytoplasm before enclosure. If this 
suggested mechanism proves to be accurate, then fusion 
may not be the only process whereby giant granules can 
evolve, even though they may continue to expand by fusion 
with lysosomal organelles after initial formation. 
Monocytes 
Monocytes from the peripheral blood of patients with CHS 
represent an enigma. The few investigators who have re-
corded the frequency of enlarged granules indicate that less 
than 10% ofthe cells contain giant inclusions (40-43). Their 
size is not very impressive, ranging from areas with four or 
five azurophilic granules close together to single inclusions 
0.1 to 4.6 fj. in diameter. Particles 0.1 /x in diameter cannot 
be distinguished from granules in normal monocytes, and 
cells with bigger inclusions may actually be large CHS 
lymphocytes containing giant granules mistaken for mono-
cytes. In our experience, giant organelles ofthe types found 
in granulocytes or lymphocytes are extremely rare in mono-
cytes from human patients with CHS. Yet, recent publica-
tions (30) would indicate that CHS monocytes are 
commonly involved in the disease process and often contain 
giant organelles. Studies in animal models of the human 
disease indicate that 10% ofthe monocytes in mink and 28% 
in cattle with CHS have abnormal granules (44). Although 
precise figures have not been provided forthe monocytes of 
mice with CHS, the literature suggests that enlarged lyso-
somes appear frequently (23, 24, 27, 28). Insofar as the 
monocyte is concerned, the human disease does not appear 
to conform with the animal models of CHS. 
Nevertheless, there is some evidence that human CHS 
monocytes may be involved in the disease process. In thin 
sections, over 30% of the cells do have manifestations 
of the disorder. However, the nature of the changes differs 
significantly from those observed in granulocytes and lym-
phocytes. Instead of forming massive inclusions of fused 
granules typical of those observed in PMN and eosinophils, 
the monocyte develops, almost exclusively, the double-
ringed organelles discussed above as the third form of 
inclusion occurring in PMN (Figs. 14, 15). The steps in 
formation of the ring-like structures were described in detail 
in an earlier publication (12) and will be discussed in a later 
report. The central space of the double-ringed organelle is 
not empty, and, in many examples, it forms a complete 
sphere enclosing a few granules or other constituents. 
Cytochemical studies demonstrated that the substance be-
tween the inner and outer membranes reacts for both acid 
phosphatase and myeloperoxidase. In other examples, 
small granules and other cytoplasmic contents trapped 
inside the double ring also stain for the two enzymes and 
undergo degenerative changes. Thus, the major alteration in 
CHS monocytes is the development of areas of cytoplasmic 
sequestration rather than formation of giant organelles 
consisting of fused granules. While the light microscope 
might show the structures as giant masses of fused granular 
material, the electron microscope demonstrates that they 
form in a very different manner from most massive inclu-
sions in CHS neutrophils, eosinophils, and lymphocytes. 
Yet, double-ringed lysosomes also form in neutrophils and 
lymphocytes and thus are not unique to CHS monocytes. 
However, because they are the major aberration in mono-
cytes from CHS patients, their formation deserves further 
study. 
Plasma cells 
Although plasma cells are rare in peripheral blood from 
patients with CHS, they occur more commonly than in 
normal blood samples (Fig. 16). Giant organelles, though 
infrequent, have been observed previously in CHS plasma 
cells (14). Their most striking feature is the peculiar arrange-
ment of their endoplasmic reticulum, which often resem-
bles cells in stages of Russell body formation (45). The 
tortuous arrangements observed are not seen in normal 
plasma cells, and their relationship to the disease is 
unknown. 
Platelets 
Platelets from patients with CHS have been virtually ignored 
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Fig. 14. CHS monocyte 
CHS monocytes are comparable in structure to normal monocytes. The 
only manifestations of CHS are double-ringed organelles ( ] ) containing 
granules and other cytoplasmic constituents (X16,000). 
Fig. 16. CHS plasma cell 
Rough endoplasmic reticulum (ER) f i l l ing the cytoplasm of the cell has a 
racemous pattern not evident in normal plasma cells (X22,500). 
Fig. 15. CHS monocyte 
This example contains two unusual double-ringed organelles ( t ) se-
questering cytoplasmic constituents (XI 5,500). 
Fig. 17. CHS platelet 
Giant granule (GG) in the cytoplasm of this example is very unusual. 
Organelles of this type have not been observed in normal platelets or in 
cells from patients wi th other inherited platelet disorders (X50,000). 
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in morphological studies, since it had been assumed that 
they do not exhibit the giant granule anomaly. The impetus 
for their closer examination came from recent studies 
suggesting that CHS platelets are very deficient in the storage 
pool of adenine nucleotides and serotonin confined to a 
specialized organelle in the cell referred to as the dense 
body (46,48). In the course of reevaluating CHS platelets 
for this deficiency, we found (Fig. 17) that rare platelets do 
contain giant organelles (49). By careful search of pe-
ripheral blood smears in the light microscope, we have also 
been able to identify giant organelles in platelets, but they 
occur so infrequently it is doubtful they influence platelet 
function. Still, their presence in platelets indicates that the 
basic CHS defect exists in this cell line and may influence 
hemostatic function. Precisely how the basic pathologic 
process results in platelet storage pool disease remainsto be 
determined. 
Discussion 
The characteristic giant granulations found in nearly all 
types of leukocytes in the peripheral blood of CHS patients 
have fascinated investigators since the disease was first 
described (1-4). Of the more than two hundred publications 
devoted to the disorder, most have focused on the blood cell 
defect, with emphasis on giant granules in PMN. The 
emphasis is well placed, for a major problem of children 
with CHS is their susceptibility to infection, and neutrophil 
dysfunction may play a principal role in failure of patient 
host defense (7). 
However, the preoccupation with giant PMN granules may 
have obscured important details ofthe pathologic process. 
The many studiesof CHS neutrophils and their bone marrow 
precursors have resulted in the concept that the massive 
inclusions arise by fusion of small azurophilic granules in 
promyelocytes and myelocytes, a process believed to be 
complete by the time the cell reaches the peripheral cir-
culation (17,18,25,26). Observations on the mechanism of 
giant granule formation in PMN have been employed 
without qualification to explain the formation of massive 
inclusions in other blood cells, tissues, and organs of 
patients with CHS. 
The present study has demonstrated that the basic pathol-
ogy of CHS is far more complex than can be deduced from 
a single cell type. Even in the PMN simple fusion of 
azurophilic granules cannot completely explain the origin 
of massive inclusions, their effects on other organelles in 
neutrophil cytoplasm, and their deleterious influence on 
cell functions. We have shown (11, 12, 31) thatthe process 
of granule fusion continues in the mature PMN and in-
volves specific granules as well as azurophilic lysosomes. 
Furthermore, the influence ofthe disease process extends 
to areas of PMN cytoplasm apart from the huge inclusions, 
resulting in the development of zones of cytoplasmic se-
questration (12). The multiple defects present in CHS neu-
trophils may all contribute to defective function ofthe cells 
and to their early demise. 
It was both logical and fortuitous that the concept of giant 
granules arising solely by fusion of azurophilic lysosomes 
in bone marrow precursors could be extended to explain 
massive inclusions in eosinophils: logical because the 
eosinophil and PMN are similar in many respects and arise 
from the same stem cell in bone marrow; fortuitous be-
cause the eosinophil in humans is reputed to have only a 
single type of storage organelle containing a distinctive 
crystalloid. Electron microscopic studies demonstrated that 
giant granules of CHS eosinophils appeared to develop by 
fusion of smaller azurophilic lysosomes in promyelocytes 
and myelocytes, a process supported by finding multiple 
crystalloid inclusions in the massive inclusions. However, 
even for the eosinophil, the concept may be simplistic. In 
many eosinophils, growth ofthe giantorganelles continues 
in mature cells, and some of them show signs of internal 
disintergration. Normal-sized azurophilic granules are pre-
sent among the massive inclusions, and rare areas of the 
cytoplasm reveal changes suggestive ofthe second form of 
giant, irregular granule observed in PMN. The rarity ofthe 
latter form in CHS eosinophils and its high frequency in 
CHS neutrophils should have suggested a significant dif-
ference in processes leading to giant granule formation in 
the two types of granulocytes. Apparently it did not, and, as 
a result, the concept of azurophil granule fusion in bone 
marrow precursor cells is still regarded by many as the only 
mechanism of giant granule formation in CHS peripheral 
blood PMN, eosinophils, and other leukocytes. 
Many workers appear to have extended the same concept 
to giant granules in the monocyte (28), but, as applied to 
CHS granulocytes, it is not tenable. Light microscopic 
studies have indicated that 10% or less of peripheral blood 
monocytes from CHS patients contain giant organelles 
(40-43), which consisted of four or five azurophilic gran-
ules close together in one area of the cytoplasm. Large 
inclusions were described in a few CHS monocytes, but 
their cells may have been large lymphocytes. Smears from 
five different patients here failed to reveal any typical giant 
azurophilic lysosomes in their monocytes. 
The CHS monocyte, however, does show manifestations of 
the disease. In thin sections, more than a third reveal 
various stages in the formation of double-ringed structures 
enclosing areas of the cytoplasm or surrounding small 
groups of azurophilic granules. In our earlier studies, we 
demonstrated the sequential formation of double rings and 
showed that the substance between the two rings of mem-
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brane was acid phosphatase positive. Recently, we have 
shown that both this substance and the encircled granules 
are peroxidase positive. While double-ringed, spherical 
organelles have also been identified in CHS lymphocytes 
and PMN, they are far more common in the monocyte. In 
our opinion, they constitute the major manifestation of 
CHS in this cell type. As shown previously, this unusual 
organelle arises by fusion, but the structures involved in its 
formation do not appear to be typical azurophilic granules, 
even though the substance between the double-ringed 
membranes stains for acid phosphatase and peroxidase, 
which are constituents of the lysosomal granules of the 
monocyte. Instead, the structural elements appear to de-
velop from small, atypical granules, from segments ofthe 
terminal cisternae of the Golgi zone, or from elements of a 
specialized region of Golgi-associated, smooth endo-
plasmic reticulum, referred to as the Golgi-endoplasmic-
reticulum-lysosome (GERL). Although further studies will 
be required to establish their precise origin, it is clear that 
giant organelle formation in monocytes does not involve a 
fusion process like that proposed for giant inclusions in 
granulocytes. 
The lymphocyte also poses a problem for the accepted 
concept of fusion of azurophilic lysosomes, since about 
75% of CHS lymphocytes on peripheral blood smears 
contain one or two giant inclusions. Study of thin sections 
of the cells has confirmed this high frequency and has also 
shown that there are two types of giant inclusions in CHS 
lymphocytes. The first variety is a complex organelle con-
taining homogenous protein or constituents resembling 
lipid droplets, ceroid or lipofuchsin pigment, or debris. We 
have observed stages of fusion between small granules in 
CHS lymphocytes that resulted in this type of large inclu-
sion. It reacts for acid phosphatase, and the asymmetric 
distribution of enzyme reaction product suggests that it 
arises by fusion of smaller granules (11). The organization of 
reaction product also suggests that fusion occurs between 
lysosomes and nonlysosomal organelles. The second vari-
ety of giant organelle is composed of tightly packed masses 
of circular profiles very similar in appearance to micro-
tubules (34). It appears to result from masses of tubules 
aggregating in an area of the cytoplasm, followed by 
enclosure within a membrane. The origin ofthe microtubu-
lar material and the enclosing membrane are uncertain. 
Small granules and cytoplasmic constituents are found 
occasionally within the membrane, and debris surrounding 
the tubules has been observed to react for acid phos-
phatase. These giant tubular inclusions do not result by 
fusion of azurophilic lysosomes, but by a process resem-
bling cytoplasmic sequestration. Even though lysosomal 
granules may subsequently fuse with and convert them to 
secondary lysosomes, the mechanism of formation is not 
consistent with the concept proposed to explain the forma-
tion ofgiant inclusions in CHS granulocytes. 
Conclusion 
The present study has demonstrated that the CHS anomaly 
of circulating blood cells is far more complex than the 
prevailing view would suggest. Although fusion of 
azurophilic granules takes place in bone marrow precur-
sors of the granulocyte series and is the major factor 
contributingto the massive inclusions in CHS eosinophils, 
it is not limited to interactions between azurophilic gran-
ules in precursor cells. It continues at all stages of leukocyte 
development and involves secondary granules and other 
cytoplasmic components, as well as azurophilic lyso-
somes, in mature CHS neutrophils. Striking differences in 
fusion processes observed in PMN and eosinophils empha-
size the importance of looking for features of the disease 
unique to each cell type, as well as for aspects common to 
all CHS cells. 
Studies of CHS monocytes and lymphocytes are also perti-
nent, as examination ofthe anomaly in CHS monocytes has 
shown a process of producing enlarged organelles far 
different from the mechanism proposed for giant inclusions 
in granulocytes. When viewed in the light microscope, a 
few CHS monocytes may appear to contain masses of fused 
azurophilic granules, but electron microscopy reveals that 
the mechanism of their formation is quite distinct from the 
process of azurophilic granule fusion in PMN and 
eosinophils. Lymphocytes, which manifest two varieties of 
giant granule formation, are both similar to CHS gran-
ulocytes and different. 
It is our hope that emphasis on the differences peculiar to 
each cell type, as well as the similarities, will lead to a 
solution to the basic defect of the CHS anomaly. 
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